This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Hangzhou Canhelp Genomics Technology Co. Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Jinying Chen in Cancer Detection
Introduction
Jinying Chen is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of genomics, particularly in the detection and classification of various cancers. With a total of 2 patents, his work has the potential to greatly enhance clinical practices in oncology.
Latest Patents
One of Jinying Chen's latest patents is a set of genes for bladder cancer detection and use thereof. This invention discloses a set of 32 genes, including CA9, CDK1, and ERBB2, which are utilized for the non-invasive detection of bladder cancer. The kit developed from this invention offers high accuracy and objective interpretation of results, significantly improving patient compliance compared to traditional cystoscopy methods. This innovation holds important clinical significance for early detection and postoperative monitoring of bladder cancer.
Another notable patent by Jinying Chen is a set of genes for the molecular classifying of medulloblastoma. This invention includes 24 genes, such as EPHA7 and OTX2, and provides a method for accurately differentiating between various subgroups of medulloblastoma. The genome's application in preparing a kit and gene chip for molecular classification has important implications for precise patient treatment, offering objective results and a short experimental period.
Career Highlights
Jinying Chen is currently associated with Hangzhou Canhelp Genomics Technology Co. Ltd. His work at this company focuses on advancing genomic technologies for cancer detection and treatment. His innovative approaches have positioned him as a key figure in the field of cancer genomics.
Collaborations
Jinying Chen collaborates with notable colleagues, including Chengshu Chen and Qifeng Wang. These partnerships enhance the research and development efforts in the field of genomics, contributing to the advancement of cancer detection technologies.
Conclusion
Jinying Chen's contributions to cancer detection through innovative genomic technologies are noteworthy. His patents reflect a commitment to improving clinical outcomes for patients with bladder cancer and medulloblastoma. The impact of his work is expected to resonate within the medical community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile